VIDEO: Dextenza reduces burden of topical medications
Click Here to Manage Email Alerts
NEW YORK — In this Healio Video Perspective from OSN New York, Mitchell A. Jackson, MD, discusses the benefits of using Dextenza as a postoperative treatment for patients after cataract surgery.
According to Jackson, the use of Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) can reduce pain and inflammation after cataract surgery, as well as eliminate the need for topical steroids.
“It reduces patient burden, staff burden and doctor burden and enhances compliance,” Jackson said.
Jackson also highlights that most commercial Medicare and Medicare Advantage patients get coverage with Dextenza.
“We’re finding about 80% of patients can get this product,” Jackson said.
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts